WATCH TAVR Watchman For Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
Study of Safety and Efficacy of Watchman Device in Patients with Irregular Heartbeat
Sponsor: Boston Scientific
Enrolling: Male and Female Patients
IRB Number: AAAR5223
U.S. Govt. ID: NCT03173534
Contact: Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu
Additional Study Information: This is a multicenter, prospective randomized study to determine the safety and efficacy of the Watchman device in patients with irregular heart beat undergoing a less invasive procedure than open heart surgery called Transcatheter Aortic Valve Replacement (TAVR). In this procedure, an x-ray is used to visualize and guide the Watchman device via a catheter to replace the heart valve. This is done for patients with aortic stenosis (AS) where there is reduced blood flow, pain and fatigue because the blood has to work harder to pump blood due to narrowed valves in the blood vessels. The watchman device is FDA approved for stroke prevention in patients with (AF). The aim is to investigate outcomes of implantation of the watchman device in patients with AF undergoing TAVR.
This study is closed
Investigator
Torsten Vahl, MD
Do You Qualify?
Do you have an irregular heartbeat? Yes No
Are you scheduled to undergo Transcatheter Aortic Valve Replacement (TAVR) procedure? Yes No
Have you had a stroke or mini stroke in the past 6 months? Yes No
Are you actively enrolled in another trial of a cardiovascular device or an investigational drug (PMA and registries excluded)? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Kate Dalton
keb2114@cumc.columbia.edu
347-514-3366